About Aveo

Science. Passion. Impact.

AVEO Pharmaceuticals integrates a proprietary cancer biology platform with drug development and commercial expertise in its efforts to discover and develop targeted cancer therapeutics. Driven by our commitment to cutting-edge science, our passion for drug development and desire to positively impact patients’ lives, AVEO is moving rapidly to bring meaningful new treatments to the medical oncology community and their patients.

AVEO is headquartered in Cambridge, Massachusetts. Shares of AVEO’s common stock trade on the NASDAQ under the symbol:  AVEO.